FindTrial
Sign In

Vasopressor and Inotrope usage pattern and outcome in neonatal shock

Profile of usage of vasopressors and inotropes and their outcome in neonatal shock: A prospective observational study in a neonatal intensive care unit - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2023/07/055210
Enrollment
50
Registered
2023-07-13
Start date
Unknown
Completion date
Unknown
Last updated
2023-07-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: P968- Other specified conditions originating in the perinatal period

Interventions

Intervention1: NIL: NIL Control Intervention1: NIL: NIL

Sponsors

Department of Pharmacology IPGMER Kolkata
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. All neonates admitted in the neonatology department who develop â??shockâ?? requiring vasopressor and /or inotrope support 2. Legally acceptable representatives who are willing to give written informed consent for study participation

Exclusion criteria

Exclusion criteria: 1. Neonates with lethal congenital malformations 2. Neonates with shock who succumbed prior to initiation of vasopressor/inotrope therapy

Design outcomes

Primary

MeasureTime frame
1 Survivor or Non-survivor of Shock 2 Cumulative dose & duration of Vasopressor or Inotrope Therapy 3 Duration of Hospital Stay 4 Treatment emergent Adverse effectsTimepoint: Admission to Death or Discharge or LAMA—

Secondary

MeasureTime frame
Outcome in subjects receiving therapeutic hypothermia for HIETimepoint: from vasopressor & or inotrope therapy initiation to Death or Discharge or LAMA—

Countries

India

Contacts

Public ContactSREYA MAZUMDER

Institute of Postgraduate Medical Education and Research Kolkata

drsupchat@gmail.com03322041428

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026